LOCALLY ADVANCED NON-SMALL CELL LUNG CANCER
Clinical trials for LOCALLY ADVANCED NON-SMALL CELL LUNG CANCER explained in plain language.
Never miss a new study
Get alerted when new LOCALLY ADVANCED NON-SMALL CELL LUNG CANCER trials appear
Sign up with your email to follow new studies for LOCALLY ADVANCED NON-SMALL CELL LUNG CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Could less be more? new study tests lower doses of cancer drug
Disease control Recruiting nowThis study is testing whether giving lower, less frequent doses of the cancer drug atezolizumab can still keep enough drug in the blood to fight cancer. About 30 adults with certain advanced cancers (like lung cancer or melanoma) will start with standard doses, then switch to a l…
Matched conditions: LOCALLY ADVANCED NON-SMALL CELL LUNG CANCER
Phase: PHASE1 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Jun 27, 2026 13:03 UTC
-
Triple-threat treatment aims to make inoperable lung cancer removable
Disease control Recruiting nowThis Phase II trial tests whether giving a short course of radiation, followed by two cycles of immunotherapy (sintilimab) plus chemotherapy, can shrink advanced lung cancer that has spread to lymph nodes on the opposite side of the chest. The goal is to make the cancer operable …
Matched conditions: LOCALLY ADVANCED NON-SMALL CELL LUNG CANCER
Phase: PHASE2 • Sponsor: Yang Hong • Aim: Disease control
Last updated Jun 27, 2026 12:26 UTC
-
New combo therapy aims to shrink lung tumors without chemo or surgery
Disease control Recruiting nowThis study tests a drug called NBTXR3 given with radiation therapy for people with locally-advanced non-small cell lung cancer who cannot have chemotherapy or surgery. The goal is to see if the combination is safe and helps control the cancer. About 40 adults with stage I to III …
Matched conditions: LOCALLY ADVANCED NON-SMALL CELL LUNG CANCER
Phase: PHASE1, PHASE2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Jun 27, 2026 12:04 UTC
-
Tailored radiation boosts survival in lung cancer trial
Disease control Recruiting nowThis study tests a new way to deliver radiation therapy for people with stage III lung cancer that cannot be removed by surgery. The treatment is personalized based on each patient's tumor sensitivity to radiation. The goal is to see if this approach helps people live longer and …
Matched conditions: LOCALLY ADVANCED NON-SMALL CELL LUNG CANCER
Phase: NA • Sponsor: Capital Medical University • Aim: Disease control
Last updated Jun 27, 2026 08:01 UTC